Diagnostic criteria for pediatric multiple sclerosis topical collection on pediatric neurology

Current Neurology and Neuroscience Reports

Volumn 13, Issue 6, 2013, Pages

  Rubin, Jennifer P ^a   Kuntz, Nancy L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ADEM; Children; CSF; Demyelinating; Diagnosis; Diagnostic criteria; MRI; Multiple sclerosis (MS); NMO; Pediatric

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADRENOLEUKODYSTROPHY; ARTICLE; CADASIL; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MELAS SYNDROME; METACHROMATIC LEUKODYSTROPHY; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PEDIATRICS; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSIENT ISCHEMIC ATTACK; BRAIN; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PEDIATRICS;

EID: 84878110395     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-013-0354-3     Document Type: Article

References (38)

1. Krupp LB, Hertz DP. Pediatric multiple sclerosis and related disorders. Neurology. 2007;68(Suppl 2).
2. Chitnes T. Pediatric multiple sclerosis. Neurologist. 2006;12(6):299-310. (Pubitemid 44813666)
3. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol. 2011;69:292-302. In an effort to improve early diagnosis of MS using clinical and paraclinical data, an international panel of experts created guidelines for the diagnostic criteria of MS referred to as the McDonald Criteria, which were revised in 2005, and then again in 2010. The most recent modifications are intended to be simplified and to apply to a more diverse patient population including children.
4. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007;68 Suppl 2:S7-12. (Pubitemid 46626001)
5. Hahn JS, Pohl D, Rensel M, et al. Differential diagnosis and evaluation in pediatric multiple sclerosis. Neurology. 2007;68 Suppl 2:S13-22. (Pubitemid 46626002)
6. Kornek B, Schmitl B, Vass K, Zehetmayer S, Pritsch M, Penzien J, et al. Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome. Mult Scler. available at http://msj.sagepub.com/ content/early/2012/04/23/1352458512444661. Performed retrospective analysis of brain and spine imaging from 52 children with clinically isolated syndrome and assessed sensitivity, specificity, and accuracy of the 2010 McDonald, 2005 McDonald, Callen, KIDMUS, and the Canadian Demyelinating Disease Network criteria.
7. Waldman AT, Gorma MP, Rensel MR. Management of pediatric nervous system demyelinating disorders: consensus of United States Neurologists. J Child Neurol. 2011;26(6):675-82.
8. Tenembaum S, Chitnis T, Ness J. Acute disseminated encephalomyelitis. Neurology. 2007;68 Suppl 2:S23-36. (Pubitemid 46626003)
9. Banwell B, Tenembaum S, Lennon VA, Ursell E, Kennedy J, Bar-Or A, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008;70:344-52. (Pubitemid 351653396)
10. Ness JM, Chabas D, Sadovnick AD, Pohl D, Banwell B, Weinstock-Guttman B. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007;68 Suppl 2:S37-45. (Pubitemid 46626004)
11. Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology. 2002;59:1922-8. (Pubitemid 36076565)
12. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med. 2000;343:898-904.
13. Comi G, Filippi M, Barkhof F, Giancarlo C, Durelli L, Edan G, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet. 2001;357:1576-82. (Pubitemid 32488815)
14. Pohl D, Waubant E, Banwell B, Chabas D, Chitnis T, Weinstock-Guttman B, et al. Treatment of pediatric multiple sclerosis and variants. Neurology. 2007;68 Suppl 2:S54-65. (Pubitemid 46626006)
15. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin F, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50:121-7.
16. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005;58:840-6. (Pubitemid 41746873)
17. Sadaka Y, Verhey LH, Shroff MM, Branson HM, Arnold DM, Narayanan S, et al. 2010 McDonald Criteria for diagnosing pediatric multiple sclerosis. Ann Neurol. 2012;72:211-23. The 2010 and 2005 McDonald Criteria were applied to a prospective cohort of pediatric subjects (209 participants) with clinically isolated syndromes of the central nervous system, three-fourths of who had non-ADEM presentations. In this prospective cohort of pediatric subjects with non-ADEM acute demyelinating syndromes the new McDonald criteria were sensitive and specific for the diagnosis of pediatric MS.
18. Callen DJA, Shroff MM, Branson HM, Totze T, Li DK, Stephens D, et al. MRI in the diagnosis of pediatric multiple sclerosis. Neurology. 2009;72:961-7.
19. Mikaeloff Y, Adamsbaum C, Husson B, Vallée L, Ponsot G, Confavreux C, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in children. Brain. 2004;127:1942-7.
20. Verhey LH, Branson HM, Shroff MM, Callen DJA, Sled JG, Narayanan S, et al. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol. 2001;10:1065-73.
21. Belman AL, Chitnis T, Renoux C, et al. Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology. 2007;68 Suppl 2:S70-4. (Pubitemid 46626008)
22. Chitnis T, Krupp L, Yeh A, Rubin J, Kuntz N, Strober JB, et al. Pediatric multiple sclerosis. Neurol Clin. 2011;29:481-505.
23. Kaye EM. Update on genetic disorders affecting white matter. Pediatr Neurol. 2001;24(1):11-24. (Pubitemid 32140931)
24. Shapiro EG, Lockman LA, Knopman D, Krivit W. Characteristics of the dementia in late-onset metachromatic leukodystrophy. Neurology. 1994;44(4):662-5. (Pubitemid 24129993)
25. van der Knaap MS, Kamphorst W, Barth PG, Kraaijeveld CL, Gut E, Valk J. Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology. 1998;51(2):540-7. (Pubitemid 28406335)
26. Pridmore CL, Baraitser M, Harding B, Boyd SG, Kendall B, Brett EM. Alexander's disease: clues to diagnosis. J Child Neurol. 1993;8(2):134-44. (Pubitemid 23170747)
27. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999;283(5407):1482-8. (Pubitemid 29133350)
28. Mina R, Brunner HI. Pediatric systemic lupus erythematosis. Rheum Dis Clin N Am. 2010;36(1):53-80.
29. Bauman RJ, Robertson Jr WC. Neurosarcoidosis presents differently in children than in adults. Pediatrics. 2003;112(6):480-6.
30. Duzova A, Bakkaloglu A. Central nervous system involvement in pediatric rheumatic diseases: current concepts in treatment. Curr Pharm Des. 2008;14:1295-301. (Pubitemid 351997823)
31. Goo HW, Weon YC. A spectrum of neuroradiological findings in children with haemophagocytic lymphohistiocytosis. Pediatr Radiol. 2007;37:1110-7. (Pubitemid 47561839)
32. Van Rie A, Harrington PR, Dow A, Robertson K. Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective. Eur J Paediatr Neurol. 2007;11:1-9. (Pubitemid 46076105)
33. Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I. EFNS guidelines on diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2009;17(1):8-e4.
34. Oschmann P, Dorndorf W, Hornig C, Schefer C, Wellensilk HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245:262-72. (Pubitemid 28230531)
35. Fernandez RE, Rothberg M, Ferencz G, Wujack D. Lyme disease of the CNS: MR imaging findings in 14 cases. AJNR. 1990;11:479-81. (Pubitemid 20232823)
36. Bitnun A, Ford-Jones E, Blaser S, Richardson S. Mycoplasma pneumoniae encephalitis. Semin Pediatr Infect Dis. 2003;14(2):96-107. (Pubitemid 36859263)
37. Chamberlain MC, Gilant ZM, Groves MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009;36(4Suppl 2):S35-45.
38. Fattapposta F, Restuccia R, Pirro C, Malandrini A, Locuratolo N, Amabile G, et al. Early diagnosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): the role of MRI. Funct Neurol. 2004;19(4):239-42. (Pubitemid 40468288)